These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21348994)

  • 1. Three therapeutic tendencies for secondary prevention of myocardial infarction and possible role of Chinese traditional patent medicine: viewpoint of evidence-based medicine.
    Shang H; Chen J; Zhang J; Xiang Y; Cao H; Ren M; Wang H; Xu H; Li J; Liu D; Hu J; Wu C; Jing L; Zhang B
    J Evid Based Med; 2009 May; 2(2):84-91. PubMed ID: 21348994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional Chinese medicine for myocardial infarction: an overview.
    Dong-mei X; Jun-hua Z; Li-yuan K; Ming-jun Z; Hong-cai S
    Int J Clin Pract; 2013 Dec; 67(12):1254-60. PubMed ID: 24246206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary prevention in acute myocardial infarction].
    Ferreira R; Ferreira D; Correia MJ; De Sá ME; De Sousa JV; Sousa JV; Tavares MG
    Acta Med Port; 2001; 14(2):149-69. PubMed ID: 11475986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based, cost-effective risk stratification and management after myocardial infarction. California Cardiology Working Group on Post-MI Management.
    Deedwania PC; Amsterdam EA; Vagelos RH
    Arch Intern Med; 1997 Feb; 157(3):273-80. PubMed ID: 9040293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence based secondary prevention following a myocardial infarction (MI): the new NICE guideline.
    Minhas R; Cooper A; Walsh JD; Williams H; Nherera L;
    Int J Clin Pract; 2007 Oct; 61(10):1604-7. PubMed ID: 17877645
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary prevention of myocardial infarction: putting the evidence to use.
    Herzog E; Javed F
    Arch Intern Med; 2010 Aug; 170(15):1381-2. PubMed ID: 20696965
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical orientation of post-marketing Chinese patent drugs: an evidence-based practice].
    Shang HC; Zhang BL; Li YP
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):887-90. PubMed ID: 18782528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary on the American Heart Association's Pharmaceutical Roundtable-Spina Outcomes Center papers.
    Wennberg DE; Malenka DJ
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):227-8. PubMed ID: 21406670
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary prevention for patients following a myocardial infarction: summary of NICE guidance.
    Skinner JS; Cooper A; Feder GS;
    Heart; 2007 Jul; 93(7):862-4. PubMed ID: 17569811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Process and key points of clinical literature evaluation of post-marketing traditional Chinese medicine].
    Liu H; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2848-50. PubMed ID: 22292382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increasing dosage: a momentous proposition to improve therapeutic efficacy of traditional Chinese medicine].
    Xiao XH; Yan D; Jin C; Zhao YL
    Zhongguo Zhong Yao Za Zhi; 2008 Feb; 33(3):229-32. PubMed ID: 18536452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)].
    Tebbe U; Messer C; Stammwitz E; The GS; Dietl J; Bischoff KO; Schulten-Baumer U; Tebbenjohanns J; Gohlke H; Bramlage P;
    Dtsch Med Wochenschr; 2007 Jul; 132(30):1559-66. PubMed ID: 17628839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lunar phases, myocardial infarction and hemorrheological character. A Western medical study combined with appraisal of the related traditional Chinese medical theory.
    Sha LR; Xu NT; Song XH; Zhang LP; Zhang Y
    Chin Med J (Engl); 1989 Sep; 102(9):722-5. PubMed ID: 2517088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Design, implementation and methodological issues in cohort study].
    Liu JP
    Zhong Xi Yi Jie He Xue Bao; 2008 Apr; 6(4):331-6. PubMed ID: 18405596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Developing evidence based guidelines on cardiac rehabilitation - phase 1: a qualitative review].
    Bitzer EM; Aster-Schenck IU; Klosterhuis H; Dörning H; Rose S
    Rehabilitation (Stuttg); 2002 Aug; 41(4):226-36. PubMed ID: 12168147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A database on treating drug addiction with traditional Chinese medicine.
    Min X; Lee DT; Jinhua X; Wenjun D; Li C; Bin D; Pingxiang D; Wingho L; Xiaoyin T; Xiaohui Z
    Addiction; 2007 Feb; 102(2):282-8. PubMed ID: 17222283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention and Sanfujin Tianjin therapy of traditional Chinese medicine].
    Yeh ML
    Hu Li Za Zhi; 2006 Aug; 53(4):74-7. PubMed ID: 16874605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Developing an evidence based clinical guideline on cardiac rehabilitation--Phase 2: comparative analysis of the present level of service provision in cardiac rehabilitation based on the KTL statistics].
    Bitzer EM; Klosterhuis H; Dörning H; Rose S
    Rehabilitation (Stuttg); 2003 Apr; 42(2):83-93. PubMed ID: 12701001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation.
    Piepoli MF; Corrà U; Benzer W; Bjarnason-Wehrens B; Dendale P; Gaita D; McGee H; Mendes M; Niebauer J; Zwisler AD; Schmid JP;
    Eur J Cardiovasc Prev Rehabil; 2010 Feb; 17(1):1-17. PubMed ID: 19952757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current quality research situation of precious Chinese patent medicine].
    Lin L; Liu XQ; Xu H
    Zhongguo Zhong Yao Za Zhi; 2008 Feb; 33(3):329-33. PubMed ID: 18536475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.